PFIZER INC
10-Q, EX-27, 2000-11-15
PHARMACEUTICAL PREPARATIONS
Previous: PFIZER INC, 10-Q, 2000-11-15
Next: POTLATCH CORP, 8-K, 2000-11-15



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM PFIZER INC.
AND SUBSIDIARY COMPANIES CONDENSED CONSOLIDATED BALANCE SHEET FOR OCTOBER 1,
2000 AND CONDENSED CONSOLIDATED STATEMENT OF INCOME FOR THE NINE MONTHS ENDED
OCTOBER 1, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>1,000,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               OCT-01-2000
<CASH>                                           1,341
<SECURITIES>                                     5,883
<RECEIVABLES>                                    5,638
<ALLOWANCES>                                     (227)
<INVENTORY>                                      2,723
<CURRENT-ASSETS>                                17,168
<PP&E>                                          14,014
<DEPRECIATION>                                 (4,836)
<TOTAL-ASSETS>                                  33,488
<CURRENT-LIABILITIES>                           12,344
<BONDS>                                          1,257
                               00
                                         00
<COMMON>                                           336
<OTHER-SE>                                      27,917
<TOTAL-LIABILITY-AND-EQUITY>                    33,488
<SALES>                                         21,468
<TOTAL-REVENUES>                                21,468
<CGS>                                            3,556
<TOTAL-COSTS>                                    3,556
<OTHER-EXPENSES>                                 3,172
<LOSS-PROVISION>                                    16
<INTEREST-EXPENSE>                                 309
<INCOME-PRETAX>                                  3,862
<INCOME-TAX>                                     1,549
<INCOME-CONTINUING>                              2,306
<DISCONTINUED>                                      00
<EXTRAORDINARY>                                     00
<CHANGES>                                           00
<NET-INCOME>                                     2,306
<EPS-BASIC>                                        .37
<EPS-DILUTED>                                      .36


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission